Mach7 Technologies Ltd operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mach7 Technologies Ltd with three other
companies in this sector in AUSTRALIA :
Cyclopharm Ltd
(2020
sales of 14.68 million Australian Dollars [US$11.19 million]
of which 99%
was Technegas),
Genetic Signatures Ltd
(14.09 million Australian Dollars [US$10.74 million]
), and
Nova Eye Medical Ltd
(12.82 million Australian Dollars [US$9.77 million]
of which 90%
was iTrack).
Sales Analysis.
Mach7 Technologies Ltd reported sales of A$18.86 million (US$14.38 million)
for the
fiscal
year ending
June of 2020.
This
represents
an
increase of 101.8%
versus 2019, when the company's sales were A$9.35 million.
Sales of Software Licenses saw an increase
that was more than double the company's growth rate: sales were up
225.8% in 2020, from
A$3.35 million to A$10.92 million.